(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HYDROSPAN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HYDROSPAN

ST13

US500000079444223

Class

5

Filing

79444223

Registration

8340245

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

08/11/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

12/24/2025

Registration date

07/14/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/14/2026

Last transaction

08/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

77

Owner location

IE

Examiner

JANSON, ANDREW KYLE

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Bausch Health Ireland Limited

Representatives

Jeremy Blackowicz Bausch Health Companies

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of blood conditionsdiseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditionsdiseasesdisorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of endocrine conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of hepatic conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of immunological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of metabolic conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of muscular conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of neurological conditionsdiseasesdisorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of renal conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of urological conditionsdiseasesdisorders; pharmaceutical preparations for the prevention and treatment of viral diseases.

Publications

History of USPTO decisions and trademark events.

20 publications found

LIMN

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED

08/11/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/14/2026

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

06/18/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/26/2026

PUBO

PUBLISHED FOR OPPOSITION

05/26/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/20/2026

RFNT

REFUSAL PROCESSED BY IB

05/14/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/29/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/28/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/28/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/28/2026

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/26/2026

RFRR

REFUSAL PROCESSED BY MPU

04/26/2026

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/14/2026

CNRT

NON-FINAL ACTION WRITTEN

03/13/2026

DOCK

ASSIGNED TO EXAMINER

03/11/2026

MAFR

APPLICATION FILING RECEIPT MAILED

02/20/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/20/2026

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/19/2026

Continuous trademark protection

Get notified about every new filing that threatens HYDROSPAN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.